SEC Form D · filed November 7, 2019
Lysosomal Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Carole E. Nuechterlein · Cambridge, MADirectorCornelis Been · Cambridge, MAExec · DirectorBruce L. Booth · Cambridge, MADirectorDaniel Geffken · Cambridge, MAExecSteven E. Hall · Cambridge, MADirectorRobert Carpenter · Cambridge, MAExec · DirectorClay E. Thorp · Cambridge, MADirectorWarren J. Olsen · Denver, CODirectorAnabatic GP, LLC · Oak Brook, ILExecBruce L. Booth · Cambridge, MADirectorLukasz Gottwald · El Segundo, CAExec · DirectorTerrell L. Winstead · Jackson, MSDirectorAnabatic Investment Partners, LLC · Oak Brook, ILDirector22Nw, LP · Seattle, WAExec · Director22Nw Fund GP, LLC · Seattle, WAExec · DirectorRussell J. Matthews · Denver, CODirectorDavid Bree · GEORGETOWN, GRAND CAYMAN, Cayman IslandsExec · DirectorThomas E. Lynch · Boca Raton, FLDirectorTammy Savage · Seattle, WADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗